An Open-Label Study to Evaluate the Effects of Ketoconazole and the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Repeat Doses of Pazopanib in Subjects With Solid Tumor Malignancies.
Phase of Trial: Phase IV
Latest Information Update: 22 May 2012
At a glance
- Drugs Esomeprazole; Ketoconazole; Pazopanib
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 02 Sep 2011 Actual end date August 2011 added as reported by ClinicalTrials.gov record
- 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.